The symposium on August 21 is taking place during the American Chemical Society’s national conference in Philadelphia.
Top researchers in conjugated linoleic acid (CLA) will present their latest findings in both humans and animals in an August 21 symposium during the American Chemical Society’s national conference in Philadelphia. The CLA symposium, titled “CLA: A Naturally Occurring, Anti-Obesity, Anti-Inflammatory Fatty Acid,” is being co-sponsored by BASF Nutrition & Health (Florham Park, NJ). BASF supplies its Tonalin brand of CLA for human food, beverages, and supplements, and its Lutrell and Lutalin CLA brands for livestock.
CLA is a fatty acid derived from natural safflower oil and is promoted for health benefits in humans, such as maintaining optimal body composition. It has also shown effects for restoring CLA levels in cows to levels that would be present if they were pasture-fed.
BASF says the symposium is being held in honor of Michael W. Pariza, PhD, an emeritus professor of food science and emeritus director of the Food Research Institute at the University of Wisconsin-Madison. Pariza is widely recognized as the founder of the modern field of CLA research.
“It is most gratifying to see the emerging clinical research on the positive effects of CLA in humans-for example, reducing body fat while maintaining lean muscle, enhancing the immune system, and other potential benefits,” Pariza said. “Important applications of CLA in animal agriculture include improving the vitality of dairy cows, and potentially reducing the need for antibiotics in poultry. This is an exciting time for CLA research.”
The CLA symposium presentations will include:
The symposium is also sponsored by the Wisconsin Alumni Research Foundation (WARF), the ACS’s Agricultural and Food Chemistry and Agrochemicals Divisions, and ACS Kansas City Section.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.